Venus Concept Price to Sales Ratio 2016-2025 | VERO
Historical PS ratio values for Venus Concept (VERO) over the last 10 years. The current P/S ratio for Venus Concept as of November 07, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Venus Concept P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-11-07 | 1.93 | 0.03 | |
| 2025-06-30 | 2.37 | $76.64 | 0.03 |
| 2025-03-31 | 2.79 | $91.59 | 0.03 |
| 2024-12-31 | 4.14 | $102.54 | 0.04 |
| 2024-09-30 | 6.71 | $111.98 | 0.06 |
| 2024-06-30 | 8.61 | $124.29 | 0.07 |
| 2024-03-31 | 7.60 | $138.95 | 0.05 |
| 2023-12-31 | 12.98 | $151.89 | 0.09 |
| 2023-09-30 | 21.56 | $179.31 | 0.12 |
| 2023-06-30 | 23.10 | $198.71 | 0.12 |
| 2023-03-31 | 36.17 | $228.48 | 0.16 |
| 2022-12-31 | 52.80 | $253.46 | 0.21 |
| 2022-09-30 | 72.60 | $291.55 | 0.25 |
| 2022-06-30 | 76.53 | $311.91 | 0.25 |
| 2022-03-31 | 235.95 | $320.31 | 0.74 |
| 2021-12-31 | 280.50 | $321.54 | 0.87 |
| 2021-09-30 | 414.15 | $339.01 | 1.22 |
| 2021-06-30 | 513.15 | $348.49 | 1.47 |
| 2021-03-31 | 387.75 | $354.08 | 1.10 |
| 2020-12-31 | 285.45 | $364.99 | 0.78 |
| 2020-09-30 | 382.80 | $866.01 | 0.44 |
| 2020-06-30 | 575.85 | $1,665.29 | 0.35 |
| 2020-03-31 | 585.75 | $2,540.39 | 0.23 |
| 2019-12-31 | 775.50 | $3,307.73 | 0.23 |
| 2019-09-30 | 1608.50 | $5,732.78 | 0.28 |
| 2019-06-30 | 1509.75 | $5,188.49 | 0.29 |
| 2019-03-31 | 1460.25 | $4,693.23 | 0.31 |
| 2018-12-31 | 1078.11 | $4,273.43 | 0.25 |
| 2018-09-30 | 7177.51 | $3,183.06 | 2.25 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.003B | $0.065B |
| Venus Concept Inc. designs and develops medical aesthetic equipment. The company's product portfolio consists of aesthetic device platforms, including Venus Versa(TM), Venus Legacy(TM), Venus Velocity(TM), Venus Fiore(TM), Venus Viva(TM), Venus Freeze Plus(TM) and Venus Bliss(TM). It also provides NeoGraft(R), an automated hair restoration system; ARTAS(R) and ARTAS Ix(TM) Robotic Hair Restoration Systems. Venus Concept Inc., formerly known as Restoration Robotics Inc., is based in TORONTO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $212.643B | 25.27 |
| Intuitive Surgical (ISRG) | United States | $196.366B | 76.83 |
| IDEXX Laboratories (IDXX) | United States | $56.993B | 56.60 |
| Edwards Lifesciences (EW) | United States | $47.840B | 32.08 |
| Alcon (ALC) | Switzerland | $36.633B | 24.59 |
| IQVIA Holdings (IQV) | United States | $35.909B | 20.02 |
| Mettler-Toledo (MTD) | United States | $29.655B | 34.41 |
| STERIS (STE) | Ireland | $25.613B | 26.35 |
| DexCom (DXCM) | United States | $22.629B | 31.19 |
| Waters (WAT) | United States | $22.097B | 29.23 |
| Hologic (HOLX) | United States | $16.492B | 17.36 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.914B | 0.00 |
| Penumbra (PEN) | United States | $10.363B | 72.89 |
| Globus Medical (GMED) | United States | $8.334B | 17.33 |
| Masimo (MASI) | United States | $7.726B | 24.76 |
| Sysmex ADR (SSMXY) | Japan | $6.572B | 20.88 |
| Teleflex (TFX) | United States | $4.795B | 7.64 |
| Glaukos (GKOS) | United States | $4.698B | 0.00 |
| TransMedics (TMDX) | United States | $4.271B | 50.60 |
| Veracyte (VCYT) | United States | $3.296B | 37.56 |
| Alphatec Holdings (ATEC) | United States | $2.898B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.707B | 14.62 |
| Integer Holdings (ITGR) | United States | $2.335B | 10.96 |
| Artivion (AORT) | United States | $2.241B | 103.26 |
| Nihon Kohden (NHNKY) | Japan | $1.975B | 23.58 |
| PROCEPT BioRobotics (PRCT) | United States | $1.741B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $1.710B | 16.57 |
| AxoGen (AXGN) | United States | $1.106B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.102B | 0.00 |
| IRadimed (IRMD) | United States | $1.076B | 51.28 |
| Pulse Biosciences (PLSE) | United States | $1.066B | 0.00 |
| OPKO Health (OPK) | United States | $1.059B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.901B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.874B | 4.73 |
| SiBone (SIBN) | United States | $0.655B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.580B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.535B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.533B | 31.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.519B | 10.35 |
| ClearPoint Neuro (CLPT) | United States | $0.518B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.483B | 0.00 |
| NeuroPace (NPCE) | United States | $0.426B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.415B | 3.26 |
| Mesa Laboratories (MLAB) | United States | $0.412B | 11.41 |
| OrthoPediatrics (KIDS) | United States | $0.411B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.394B | 0.00 |
| RxSight (RXST) | United States | $0.354B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.323B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.305B | 50.82 |
| Spectral Diagnostics (EDTXF) | Canada | $0.295B | 0.00 |
| 908 Devices (MASS) | United States | $0.280B | 0.00 |
| CVRx (CVRX) | United States | $0.263B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.262B | 0.00 |
| Inogen (INGN) | United States | $0.190B | 0.00 |
| Neuronetics (STIM) | United States | $0.173B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.143B | 0.00 |
| Accuray (ARAY) | United States | $0.138B | 0.00 |
| LENSAR (LNSR) | United States | $0.137B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.136B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.122B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Hyperfine (HYPR) | United States | $0.083B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.082B | 0.00 |
| InspireMD (NSPR) | United States | $0.082B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.076B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.074B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.058B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.039B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
| Solana (HSDT) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.68 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |